9XX-81064-43120
1 vaccination
1 coded response
11 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2021-02-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-08
Dose 1 — Moderna
-
2021-02-09
Registered in v-safe
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-05-11
-
2021-08-09
Survey response — 6 months, dose 1MedDRA: Benign hydatidiform mole, Uterine dilation and curettage — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Molar Pregnancy · Healthcare visit (other): D&C surgeryMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-09
Report sent to call center — 6 months, dose 1Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-08 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-09 | Unsuccessful |
Free text
Release 9 — 6 months, dose 1
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Uterine dilation and curettage | ✓ | · | ✓ |
| SD | Benign hydatidiform mole | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release